Last update 21 Nov 2024
Pegfilgrastim biosimilar(Lunan Pharma)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Pegfilgrastim Biosimilar (Lunan Pharmaceutical Group Co., Ltd.), Pegylated Human Granulocyte Colony-stimulating Factor (Lunan Pharma), 培非司亭生物类似药 (鲁南制药) + [4] |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (30 Apr 2021), |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 4190
The sequence is quoted from: *****
Related
4
Clinical Trials associated with Pegfilgrastim biosimilar(Lunan Pharma)Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor secondary prophylaxis in capecitabine combined with oxaliplatin (CapeOX) regimen in the treatment of colorectal cancer
Comparison of efficacy between pegylated recombinant human granulocyte stimulating factor and recombinant human granulocyte stimulating factor in autologous peripheral blood stem cell mobilization in hematologic malignancies
聚乙二醇化重组人粒细胞集落刺激因子注射液的有效性和安全性的随机、开放、阳性药平行对照Ⅲb期临床试验
[Translation] A randomized, open-label, positive-drug parallel-controlled phase Ⅲb clinical trial on the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor injection
100 Clinical Results associated with Pegfilgrastim biosimilar(Lunan Pharma)
Login to view more data
100 Translational Medicine associated with Pegfilgrastim biosimilar(Lunan Pharma)
Login to view more data
100 Patents (Medical) associated with Pegfilgrastim biosimilar(Lunan Pharma)
Login to view more data
100 Deals associated with Pegfilgrastim biosimilar(Lunan Pharma)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Neutropenia | CN | 30 Apr 2021 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neutropenia | Phase 1 | CN | 23 May 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free